Skip to main content
Caplight Logo









Foxcroft Therapeutics, Inc.

Foxcroft Therapeutics, Inc.

Private
United StatesHealthcare & Life Scienceshttps://foxcrofttx.com/

Company Overview

Foxcroft Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in the United States. It was founded in 2025.

Foxcroft Therapeutics, Inc. is a biotechnology company that develops targeted, tumor lysate–based cancer vaccines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Foxcroft Therapeutics, Inc. Comparables

Compare Foxcroft Therapeutics, Inc. with similar companies based on industry and business-model similarity.

Foxcroft Therapeutics, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hopewell Therapeutics
81%
AbbVie
69%
Eli Lilly and Company
61%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Foxcroft Therapeutics, Inc. Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Foxcroft Therapeutics, Inc.. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Foxcroft Therapeutics, Inc. Filings

Explore SEC and related filing metadata, where available.

Foxcroft Therapeutics, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Foxcroft Therapeutics, Inc.'s valuation, stock price, and market status.

Is Foxcroft Therapeutics, Inc. a public or private company?

Foxcroft Therapeutics, Inc. is a private company.

What is the current stock price of Foxcroft Therapeutics, Inc.?

Foxcroft Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Foxcroft Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Foxcroft Therapeutics, Inc. worth (valuation)?

Valuation information for Foxcroft Therapeutics, Inc. is not publicly available.

Can I buy Foxcroft Therapeutics, Inc. stock?

Foxcroft Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Foxcroft Therapeutics, Inc.'s last funding round?

Funding round information for Foxcroft Therapeutics, Inc. is not publicly available.

Who are the main investors in Foxcroft Therapeutics, Inc.?

Investor information for Foxcroft Therapeutics, Inc. is not publicly disclosed.

Will Foxcroft Therapeutics, Inc. IPO soon?

No public IPO plans have been announced for Foxcroft Therapeutics, Inc..

How can I track Foxcroft Therapeutics, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Foxcroft Therapeutics, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersUnited States
Year Founded2025
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?